{"disease":{"id":"lymphoma-b-cell-aggressive-non-hodgkin-b-nhl","name":"lymphoma b cell aggressive non hodgkin b nhl"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06911710","title":"The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT03985696","title":"Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"University Hospital, Limoges","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}